|
1
|
Gin A, Dilay L, Karlowsky JA, Walkty A,
Rubinstein E and Zhanel GG: Piperacillin-tazobactam: A
beta-lactam/beta-lactamase inhibitor combination. Expert Rev Anti
Infect Ther. 5:365–383. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hayashi Y, Roberts JA, Paterson DL and
Lipman J: Pharmacokinetic evaluation of piperacillin-tazobactam.
Expert Opin Drug Metab Toxicol. 6:1017–1031. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Perry CM and Markham A:
Piperacillin/tazobactam: An updated review of its use in the
treatment of bacterial infections. Drugs. 57:805–843.
1999.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Linares T, Fernández A, Soto MT, Escudero
E and Gacías L: Drug fever caused by piperacillin-tazobactam. J
Investig Allergol Clin Immunol. 21:250–251. 2011.PubMed/NCBI
|
|
5
|
Wang Q, He Z, Wu X, Wei Y and Huang J:
Hematologic adverse effects induced by piperacillin-tazobactam: A
systematic review of case reports. Int J Clin Pharm. 42:1026–1035.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cabañas R, Calderon O, Ramirez E, Fiandor
A, Prior N, Caballero T, Herránz P, Bobolea I, López-Serrano MC,
Quirce S and Bellón T: Piperacillin-induced DRESS: distinguishing
features observed in a clinical and allergy study of 8 patients. J
Investig Allergol Clin Immunol. 24:425–430. 2014.PubMed/NCBI
|
|
7
|
Metlay JP, Waterer GW, Long AC, Anzueto A,
Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, et
al: Diagnosis and treatment of adults with community-acquired
pneumonia. An official clinical practice guideline of the american
thoracic society and infectious diseases society of America. Am J
Respir Crit Care Med. 200:e45–e67. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gu W, Miller S and Chiu CY: Clinical
metagenomic next-generation sequencing for pathogen detection. Annu
Rev Pathol. 14:319–338. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gagnier JJ, Kienle G, Altman DG, Moher D,
Sox H and Riley D: CARE Group. The CARE guidelines: Consensus-based
clinical case reporting guideline development. BMJ Case Rep.
2013(bcr2013201554)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Alzahrani M, Alrumaih I, Alhamad F and
Abdel Warith A: Rapid onset severe thrombocytopenia following
reexposure to piperacillin-tazobactam: Report of two cases and
review of the literature. Platelets. 29:628–631. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Beaulieu C, Kurczewski L and Yajnik V:
Cefepime challenge after piperacillin/tazobactam-induced
thrombocytopenia. J Thromb Thrombolysis. 48:167–170.
2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bai M, Govindaraj V, Kottaisamy R and
Vijayarangam N: Drug reaction with eosinophilia and systemic
symptoms syndrome related to piperacillin-tazobactam use. J
Postgrad Med. 68:102–105. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lv J, Wu G, Zhang F and Su X: An unusual
case of piperacillin-tazobactam-induced fever, eosinophilia,
thrombocytopenia and liver damage. Eur J Hosp Pharm Sci Pract.
29:e91–e94. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jafri F, Arif S and Ashraf U:
Hypersensitivity myocarditis associated with
piperacillin-tazobactam use. Chest. 158 (Suppl)(A226)2020.
|
|
15
|
Calogiuri GF, Nettis E, Di Leo E, Vacca A,
Ferrannini A and Kounis NG: Kounis syndrome induced by intravenous
administration of piperacillin/tazobactam: A case report. Int J
Cardiol. 155:e42–e44. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Abdelghany M, Subedi R, Shah S and Kozman
H: Kounis syndrome: A review article on epidemiology, diagnostic
findings, management and complications of allergic acute coronary
syndrome. Int J Cardiol. 232:1–4. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Saloojee A, Skinner DL, Loots E,
Hardcastle TC and Muckart DJJ: Hepatic dysfunction: A common
occurrence in severely injured patients. Injury. 48:127–132.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
McDonald C, Cotta MO, Little PJ, McWhinney
B, Ungerer JP, Lipman J and Roberts JA: Is high-dose β-lactam
therapy associated with excessive drug toxicity in critically ill
patients? Minerva Anestesiol. 82:957–965. 2016.PubMed/NCBI
|
|
19
|
Aun MV, Kalil J and Giavina-Bianchi P:
Drug-induced anaphylaxis. Immunol Allergy Clin North Am.
37:629–641. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bhattacharyya S, Darby RR, Raibagkar P,
Gonzalez Castro LN and Berkowitz AL: Antibiotic-associated
encephalopathy. Neurology. 86:963–971. 2016.PubMed/NCBI View Article : Google Scholar
|
